Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

Cover of the whitepaper biosimilar
The development of a biosimilar product requires extensive characterization at many stages. At the functional level, pharmacologic activity should be evaluated by appropriate in vitro and/or in vivo assays. However, these potency assays can be expensive and time consuming.
 
This paper reviews the qualification of cell-based assays for functional comparability analysis that provide an attractive alternative to more expensive and time-consuming assays.

Please complete the form to download your copy.

Fields marked with an asterisk (*) are mandatory.

White paper request form

Are you an SGS client?*

200 characters remaining